Thursday - December 25, 2025

Biomarkers and Methods for Evaluation and Treatment of Epileptic vs Non-Epileptic Seizures / No Seizures / Psychogenic Non-Epileptic Seizures

2025-12-16

ALEXANDRIA, Virginia, Dec. 16 -- COGNIZANCE BIOMARKERS, INC., Miami, Florida has been assigned a patent (No. US 12498384 B2, initially filed May 29, 2019) developed by four inventors Todd Wallach, Overland Park, Kansas; John Gledhill, Overland Park, Kansas; Richard St. Clair, Overland Park, Kansas; and Elizabeth Brand, Overland Park, Kansas, for "Biomarkers and methods for evaluation and treatment of epileptic vs non-epileptic seizures / no seizures / psychogenic non-epileptic seizures." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Biomarkers and Methods for Evaluation and Treatment of Epileptic vs Non-Epileptic Seizures / No Seizures / Psychogenic Non-Epileptic Seizures

Information Request Form

Copyright Targeted News Service 2025